Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 9:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 721–744 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Sexual Dysfunction, Physiological
Interventions: Ospemifene, Vaginal conjugated estrogens; Drug
Lead sponsor: Emory University; Other
Eligibility: 40 Years and older · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 4
States / cities: Atlanta, Georgia

Conditions: Mild Cognitive Impairment
Interventions: Elderberry Juice, Placebo; Biological · Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 50 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: GERD
Interventions: Concurrent manometry/impedance/pH with video pharyngo-laryngoscopy, Slow and rapid intra-esophageal infusion; Diagnostic Test
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 85 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Mild Cognitive Impairment, Mild Dementia, Alzheimer's Disease
Interventions: SAGE-718, SAGE-718-matching Placebo; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 37
States / cities: Gilbert, Arizona • Phoenix, Arizona • Lafayette, California + 34 more

Conditions: Postoperative Delirium, Postoperative Cognitive Dysfunction, Mild Cognitive Impairment
Interventions: Dextrose Water, Caffeine citrate; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 70 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Erectile Dysfunction
Interventions: Placebo, Avanafil; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 298 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 51
States / cities: Phoenix, Arizona • Laguna Hills, California • Los Angeles, California + 42 more

Conditions: Mild Cognitive Impairment
Interventions: Transcranial alternating current stimulation; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 60 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Mild Cognitive Impairment
Interventions: Strategic Memory Advanced Reasoning Training, Brain Health Workshop; Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 50 Years to 80 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal Insert; Drug
Lead sponsor: EndoCeutics Inc.; Industry
Eligibility: 40 Years to 80 Years · Female only
Enrollment: 653 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 63
States / cities: Huntsville, Alabama • Mobile, Alabama • Tucson, Arizona + 53 more

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: low carbohydrate/high fat diet, low fat/high carbohydrate diet; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years to 85 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Interventions: ALN-CIDEB, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 15
States / cities: Tucson, Arizona • Pasadena, California • Rialto, California + 9 more

Conditions: Multiple Sclerosis, Relapsing-Remitting, Sexual Dysfunction
Interventions: Behavioural intervention for physical activity for multiple sclerosis (BIPAMS); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Mild Cognitive Impairment, Cognitive Impairment, Insomnia
Interventions: Sleep Health Using the Internet for Older Adult Sufferers of Insomnia and Sleeplessness; Other
Lead sponsor: University of Virginia; Other
Eligibility: 55 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Prehypertension, Hypertension, Overweight and Obesity, Elevated Blood Pressure, Endothelial Dysfunction, Vascular Stiffness, Sleep
Interventions: Cardiovascular Assessments, Actigraphy, Laboratory assessments, Emotional/Behavioral Assessments; Diagnostic Test
Lead sponsor: Johns Hopkins University; Other
Eligibility: Up to 22 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Segmental and Somatic Dysfunction of Other Regions (M99.09)
Interventions: OMT; Other
Lead sponsor: New York Institute of Technology; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Jonesboro, Arkansas

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Lighting Intervention; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 50 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Albany, New York • New York, New York

Conditions: Vitamin D Deficiency, Coronary Artery Disease, Endothelial Dysfunction, Inflammation
Interventions: Ergocalciferol, Sugar pill; Drug · Other
Lead sponsor: Seth I. Sokol, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Pulmonary Artery Hypertension, Right Ventricular Dysfunction
Interventions: Temporary right ventricular pacing; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Epilepsy, Cognitive Dysfunction, Memory Disorders
Interventions: HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH) - Spanish/Espanol; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Osteopathic Manipulation, Postural; Defect, Somatic; Functional Disturbance
Interventions: Osteopathic Manipulative Treatment; Procedure
Lead sponsor: Edward Via Virginia College of Osteopathic Medicine; Other
Eligibility: 18 Years to 35 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Blacksburg, Virginia

Conditions: Mild Cognitive Impairment
Interventions: Octagam 10%; Biological
Lead sponsor: Sutter Health; Other
Eligibility: 50 Years to 84 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Peripheral Vascular Diseases
Interventions: Moderate Intensity, Normal Volume Exercise Training, High Intensity, Normal Volume Exercise Training, Moderate Intensity, High Volume Exercise Training; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Cognitive Impairment, Alzheimer Disease, Early Onset, Mild Cognitive Impairment
Interventions: Juice Plus+; Dietary Supplement
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 55 Years to 90 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Tuscaloosa, Alabama

Conditions: Obesity, Insulin Resistance
Interventions: Hesperidin, Placebo; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 21 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction

Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive Impairment

Mechanisms Preventing Pharyngeal Reflux

A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

Enhancing Cognitive Control in Mild Cognitive Impairment Via Non-invasive Brain Stimulation

Cognitive Screening and Cognitive Training in Seniors

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Brain Energy for Amyloid Transformation in Alzheimer's Disease Study

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis

Use of an Internet-Based Insomnia Intervention to Prevent Cognitive Decline in Adults With Mild Cognitive Impairment

Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth

Effects of Osteopathic Manipulative Treatment of Fascial Restrictions on Body Awareness, Mood, and Proprioception

The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment

Vitamin D Repletion in Coronary Artery Disease

Right Ventricular Pacing in Pulmonary Arterial Hypertension

Epilepsy Self-Management for Spanish Speakers: HOBSCOTCH - ESPANOL

The Ability of Osteopathic Structural Evaluation to Assess Gait

Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease

Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2

Juice Plus Supplement Clinical Trial

Effects of Hesperidin on Insulin Sensitivity